15.57
price up icon0.37%   0.08
after-market アフターアワーズ: 15.57
loading
前日終値:
$15.49
開ける:
$15.46
24時間の取引高:
1.19M
Relative Volume:
0.77
時価総額:
$2.28B
収益:
$340.81M
当期純損益:
$-419.65M
株価収益率:
-5.4632
EPS:
-2.85
ネットキャッシュフロー:
$-402.10M
1週間 パフォーマンス:
+4.90%
1か月 パフォーマンス:
+13.73%
6か月 パフォーマンス:
-19.03%
1年 パフォーマンス:
-37.24%
1日の値動き範囲:
Value
$15.32
$15.77
1週間の範囲:
Value
$14.15
$16.19
52週間の値動き範囲:
Value
$10.57
$33.33

Denali Therapeutics Inc Stock (DNLI) Company Profile

Name
名前
Denali Therapeutics Inc
Name
セクター
Healthcare (1159)
Name
電話
(650) 866-8547
Name
住所
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
Name
職員
486
Name
Twitter
Name
次回の収益日
2025-08-08
Name
最新のSEC提出書
Name
DNLI's Discussions on Twitter

DNLI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DNLI
Denali Therapeutics Inc
15.58 2.17B 340.81M -419.65M -402.10M -2.85
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
388.78 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.56 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
443.53 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
677.67 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
308.09 37.96B 3.81B -644.79M -669.77M -6.24

Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-10 アップグレード Cantor Fitzgerald Neutral → Overweight
2025-03-07 再開されました Morgan Stanley Overweight
2025-02-11 開始されました Deutsche Bank Buy
2025-01-07 開始されました Robert W. Baird Outperform
2025-01-03 開始されました William Blair Outperform
2024-12-16 アップグレード Stifel Hold → Buy
2024-10-10 再開されました Raymond James Mkt Perform
2024-10-07 ダウングレード Cantor Fitzgerald Overweight → Neutral
2023-12-13 開始されました Citigroup Buy
2023-11-20 再開されました JP Morgan Overweight
2023-10-24 再開されました Cantor Fitzgerald Overweight
2023-09-06 開始されました B. Riley Securities Buy
2023-01-30 開始されました SVB Securities Outperform
2022-12-05 開始されました Cowen Outperform
2022-11-02 アップグレード BTIG Research Neutral → Buy
2022-11-02 開始されました BofA Securities Buy
2022-06-23 開始されました Berenberg Buy
2021-12-10 再開されました Raymond James Mkt Perform
2021-09-21 開始されました Oppenheimer Outperform
2021-09-01 開始されました SMBC Nikko Outperform
2021-05-18 開始されました UBS Buy
2021-02-26 繰り返されました H.C. Wainwright Buy
2021-02-10 アップグレード Cantor Fitzgerald Neutral → Overweight
2020-11-11 繰り返されました H.C. Wainwright Buy
2020-10-16 ダウングレード BTIG Research Buy → Neutral
2020-09-14 再開されました JP Morgan Overweight
2020-08-20 繰り返されました H.C. Wainwright Buy
2020-03-13 アップグレード Evercore ISI In-line → Outperform
2020-02-28 アップグレード Wedbush Neutral → Outperform
2020-02-24 開始されました Jefferies Buy
2020-02-19 開始されました Stifel Hold
2020-01-27 アップグレード Goldman Neutral → Buy
2019-09-26 開始されました Wedbush Neutral
2019-09-13 開始されました Nomura Buy
2019-08-09 開始されました BTIG Research Buy
2019-06-26 開始されました H.C. Wainwright Buy
2018-11-15 開始されました Cantor Fitzgerald Overweight
2018-11-12 開始されました Janney Buy
2018-03-12 ダウングレード Evercore ISI Outperform → In-line
2018-01-02 開始されました Evercore ISI Outperform
2018-01-02 開始されました Goldman Neutral
2018-01-02 開始されました JP Morgan Overweight
2018-01-02 開始されました Morgan Stanley Overweight
すべてを表示

Denali Therapeutics Inc (DNLI) 最新ニュース

pulisher
Aug 20, 2025

Denali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome Therapy - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Can Denali Therapeutics Inc. Regain Lost Ground This Quarter2025 Price Targets & Smart Swing Trading Alerts - newsyoung.net

Aug 20, 2025
pulisher
Aug 16, 2025

Can Denali Therapeutics Inc. be the next market leaderEarnings Risk Report & Safe Capital Growth Tips - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Is Denali Therapeutics Inc. stock technically oversold2025 EndofYear Setup & Low Drawdown Trading Techniques - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 16, 2025

BTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target - MSN

Aug 16, 2025
pulisher
Aug 15, 2025

Why Denali Therapeutics Shares Are Slipping - TipRanks

Aug 15, 2025
pulisher
Aug 15, 2025

Is Denali Therapeutics Inc. subject to activist investor interestTrade Volume Report & AI Optimized Trade Strategies - thegnnews.com

Aug 15, 2025
pulisher
Aug 14, 2025

Denali Therapeutics Inc. Stock Approaches Key Moving Average2025 Valuation Update & Community Verified Swing Trade Signals - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Denali Therapeutics COFO Schuth sells $39884 in stock By Investing.com - Investing.com Canada

Aug 14, 2025
pulisher
Aug 14, 2025

DNLI Tops on Q2 Earnings, Expects Decree on Hunter Syndrome Drug in '26 - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

Denali therapeutics’ Ho Carole sells $52k in stock - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

Denali Therapeutics COFO Schuth sells $39884 in stock - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

Science Spotlight: How Denali’s CNS-penetrant amyloid mAb may avoid ARIA - BioCentury

Aug 14, 2025
pulisher
Aug 14, 2025

XTX Topco Ltd Lowers Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - Defense World

Aug 14, 2025
pulisher
Aug 14, 2025

Elliott Wave Theory Predicts Pullback in Denali Therapeutics Inc.July 2025 Reactions & Community Consensus Picks - beatles.ru

Aug 14, 2025
pulisher
Aug 14, 2025

Is now a turning point for Denali Therapeutics Inc.July 2025 Big Picture & Safe Entry Momentum Stock Tips - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

What makes Denali Therapeutics Inc. stock price move sharplyJuly 2025 Earnings & Smart Investment Allocation Insights - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings visualization tools for Denali Therapeutics Inc.Weekly Profit Summary & Weekly Momentum Picks - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Technical signs of recovery in Denali Therapeutics Inc.Dividend Hike & Weekly Consistent Profit Watchlists - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Denali Soars 11% on Biotech Sector Turmoil: What’s Fueling This Surge? - AInvest

Aug 13, 2025
pulisher
Aug 12, 2025

Using data filters to optimize entry into Denali Therapeutics Inc.Stock Trading Session Highlights and Summary - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowSummary of Consistent Growth Stock Picks - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics shares fall 3.52% intraday after reporting mixed Q2 2025 results and regulatory updates. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

H.C. Wainwright Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $32 - 富途牛牛

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics: Advancements in CNS Delivery and Strategic Market Positioning Drive Buy Rating - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics: Promising Developments and Regulatory Momentum Drive Buy Rating - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times

Aug 12, 2025
pulisher
Aug 11, 2025

Denali Therapeutics reports Q2 EPS (72c), consensus (74c) - TipRanks

Aug 11, 2025
pulisher
Aug 11, 2025

Denali Therapeutics: Promising Pipeline and Regulatory Progress Justify Buy Rating - TipRanks

Aug 11, 2025
pulisher
Aug 11, 2025

Denali Therapeutics Inc. SEC 10-Q Report - TradingView

Aug 11, 2025
pulisher
Aug 11, 2025

Denali Therapeutics Q2 2025 Financial Results and Business Highlights: Tividenofusp Alfa BLA Accepted for Priority Review, DNL126 Accelerated Approval Path Aligned, and More. - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

FDA Fast-Tracks Denali's Breakthrough Hunter Syndrome Drug as Pipeline Expands - Stock Titan

Aug 11, 2025
pulisher
Aug 10, 2025

Possible Bearish Signals With Denali Therapeutics Insiders Disposing Stock - 富途牛牛

Aug 10, 2025
pulisher
Aug 07, 2025

BTIG Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $32 - 富途牛牛

Aug 07, 2025
pulisher
Aug 06, 2025

Denali Therapeutics (DNLI) to Release Quarterly Earnings on Thursday - Defense World

Aug 06, 2025
pulisher
Aug 05, 2025

Catalyst Pharmaceutics to Report Q2 Earnings: What's in the Cards? - The Globe and Mail

Aug 05, 2025
pulisher
Aug 04, 2025

Is Denali Therapeutics Inc. a good long term investmentMaster stock selection with insider knowledge - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

How strong is Denali Therapeutics Inc. company’s balance sheetCapitalize on momentum stocks before they peak - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Denali Therapeutics Inc. company’s key revenue driversInvest smarter with daily market updates - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Denali Therapeutics Inc. stockFree Technical Analysis Support - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Denali Therapeutics Inc. company’s growth strategyConsistent triple-digit returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Denali Therapeutics Inc. stock overvalued or undervaluedAchieve unparalleled market performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Denali Therapeutics Inc. stock perform well during market downturnsMaximize gains with expert trading strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Denali Therapeutics Inc. generate profit in a changing economyMarket-leading profit generation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Backtesting results for Denali Therapeutics Inc. trading strategiesForecast Model for Intraday Buy Signals - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Denali Therapeutics Inc. stock compared to the marketFree Daily Trading Room Entry - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What is the risk reward ratio of investing in Denali Therapeutics Inc. stockSky-high return potential - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is Denali Therapeutics Inc. a growth stock or a value stockAccelerated financial growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are analysts’ price targets for Denali Therapeutics Inc. in the next 12 monthsInvest smarter with cutting-edge analytics - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is it the right time to buy Denali Therapeutics Inc. stockTransform your portfolio with high-yield stocks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation - MSN

Aug 02, 2025

Denali Therapeutics Inc (DNLI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Denali Therapeutics Inc (DNLI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Ho Carole
Chief Medical Officer
Aug 12 '25
Sale
13.58
2,937
39,884
217,391
Ho Carole
Chief Medical Officer
Aug 13 '25
Sale
14.64
806
11,800
216,585
$24.30
price down icon 1.34%
$84.78
price down icon 0.36%
$26.29
price up icon 0.52%
$105.07
price down icon 5.10%
$128.29
price down icon 2.79%
biotechnology ONC
$308.09
price down icon 1.65%
大文字化:     |  ボリューム (24 時間):